+467.0%
MRNA vs EMB
+3.1%
+464.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EMB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.1% | +5.5% | +5.9% |
| 7D | -1.1% | -1.2% | +0.1% | +7.7% |
| 30D | +126.1% | -1.3% | +127.4% | +153.6% |
| 3M | +190.0% | -1.8% | +191.8% | +233.9% |
| 6M | +157.2% | +0.2% | +157.0% | +181.4% |
| YTD | +388.2% | +0.4% | +387.8% | +433.4% |
| 1Y | +467.0% | +2.8% | +464.2% | +453.9% |
| All | +467.0% | +3.1% | +464.0% | +453.9% |
Cumulative growth
Daily Returns
Daily percentage return beside EMB.
Daily Out/Under-Performance
Portfolio return minus EMB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EMB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling